Shockwave Medical Inc expected to post earnings of 89 cents a share - Earnings Preview

Shockwave Medical

13/02/2024 21:26

* Shockwave Medical Inc  SWAV.OQ   SWAV.O  is expected
to show a
rise in quarterly revenue when it reports  results on February
15 for the period ending December 31 2023
    * The Santa Clara California-based  company is expected to
report
a 38.5% increase in revenue to $199.453 million from $144.03
million a year ago, according to the mean estimate from 10
analysts, based on LSEG data. (Revenue is on Total Revenue
Basis)
    * ​LSEG's mean analyst estimate for Shockwave Medical Inc is
for
earnings of 89 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Shockwave
Medical
Inc is $230.00​, below​ its last closing price of $235.64. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  0.80        0.79       0.92      Beat    15.9
 Jun. 30 2023  0.88        0.86       0.76      Missed  -11.1
 Mar. 31 2023  0.81        0.81       1.03      Beat    27.3​
 Dec. 31 2022  1.01        1.01       1.18      Beat    17.4
 ​​Sep.        0.67        0.67       0.92      Beat    37.6
 30 2022                                                
 Jun. 30 2022  0.44        0.44       0.68      Beat    54.5​
 Mar. 31 2022  0.18        0.18       0.39      Beat    111.6
 Dec. 31 2021  0.11        0.09       0.34      Beat    300
 This summary was machine generated February 13 at 21:26 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)